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NckdsRNA-activated protein kinase (PKR) is activated by viral dsRNAs and phosphorylates eIF2a reducing trans-
lation of host and viral mRNA. Although infection with a chimeric West Nile virus (WNV) efﬁciently induced
PKR and eIF2a phosphorylation, infections with natural lineage 1 or 2 strains did not. Investigation of the
mechanism of suppression showed that among the cellular PKR inhibitor proteins tested, only Nck, known
to interact with inactive PKR, colocalized and co-immunoprecipitated with PKR in WNV-infected cells and
PKR phosphorylation did not increase in infected Nck1,2−/− cells. Several WNV stem-loop RNAs efﬁciently
activated PKR in vitro but not in infected cells. WNV infection did not interfere with intracellular PKR activa-
tion by poly(I:C) and similar virus yields were produced by control and PKR−/− cells. The results indicate
that PKR phosphorylation is not actively suppressed in WNV-infected cells but that PKR is not activated by
the viral dsRNA in infected cells.Georgia State University, 623
GA 30303, USA. Fax: +1 404
of Infectious Diseases, St. Jude
, Mail Stop 330, Memphis, TN
rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
PKR is a serine/threonine kinase composed of an N-terminal regula-
tory domain that contains two dsRNA bindingmotifs (DRBMs) and a C-
terminal kinase domain (Meurs et al., 1990; Nanduri et al., 1998). These
domains are connected by a spacer that provides an interface for dimer-
ization (McKenna et al., 2007). It has been proposed that in the unpho-
sphorylated state, the N-terminal regulatory domain interacts with the
C-terminal catalytic domain to inhibit kinase activity (Nanduri et al.,
2000). Activation of PKR by dsRNA results in the formation of dimers
that are stabilized by autophosphorylation at multiple residues, includ-
ing Thr446 and Thr451 that are locatedwithin the activation loop of the
kinase domain and essential for PKR activation (Romano et al., 1998). To
date, 18 PKRphosphorylation sites have been identiﬁed.Most are serine
residues but some are threonine or tyrosine residues (Su et al., 2006;
Toth et al., 2006). Active PKR dimers eject the activating dsRNA, pre-
sumably, due to phosphorylation of N-terminal residues and then phos-
phorylate eIF2a (Jammi and Beal, 2001). PKR is constitutively and
ubiquitously expressed at low levels due to a kinase conserved se-
quence (KCS) site in its promoter (Toth et al., 2006). PKR expression is
upregulated by Type I IFN which can be produced in response to a
viral infection. The majority of PKR is located in the cytoplasm where
a portion is associated with ribosomes. Some of the PKR in the nucleusassociates with nucleoli (MacQuillan et al., 2009; Tanaka and Samuel,
1994; Toth et al., 2006).
A ternary complex consisting of GTP-eIF2 and a methionyl-tRNA de-
livers the charged initiator tRNA to the 40S ribosomal subunit of the 43S
preinitiation complex but translation initiation requires the hydrolysis of
the eIF2-bound GTP to a GDP (Hershey, 1991; Majumdar and Maitra,
2005). Under stress conditions, the alpha-subunit of eIF2 is phosphory-
lated by one of four eIF2a kinases: general control non-repressed 2
(GCN2), heme-regulated inhibitor (HRI), PKR-like endoplasmic reticu-
lum (ER) kinase (PERK), or PKR (Kaufman, 1999). The eIF2a kinases
share a conserved kinase domain that mediates eIF2a phosphorylation,
but each responds to a different stress due to its unique regulatory do-
main (Kaufman, 1999). Phosphorylation of eIF2a on Ser51 leads to the
formation of a high-afﬁnity complex with the guanine exchange factor,
eIF2B. This inhibits the exchange of GDPwith GTP and “stalls” the preini-
tiation complexes onmRNAs (Sudhakar et al., 2000). Phosphorylation of
as little as 20% of eIF2a signiﬁcantly reduces the synthesis ofmost cellular
proteins (Sudhakar et al., 2000). In virus-infected cells, PKR is activated
by viral dsRNA. However, PKR can also be activated by Type I or II IFN
by amechanismmediated by the activated JAKs of the IFN receptor com-
plex (Su et al., 2007), by heparin oligosaccharides, or by IL-3 withdrawal
(Toth et al., 2006). PKR activation by peroxide or arsenite treatment is
mediated through interaction of the activation domain of PACT with
the N-terminal domain of PKR (Ito et al., 1999; Patel et al., 2000).
WNV, a member of the genus Flavivirus within the family Flavivir-
idae, was ﬁrst isolated in 1937 from a febrile woman in the West Nile
region of Uganda (Brinton, 2002). Until 1999, WNV was mainly con-
ﬁned to Southern Europe, the Middle East, Africa, West and Central
Asia, Indonesia and Australia. In 1999, WNV extended into theWestern
hemisphere where it has since spread rapidly. The majority of WNV
infections in humans are asymptomatic. Flu-like symptoms are ob-
served in ~20% and meningitis, encephalitis and/or paralysis occur
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2007). The WNV genome is a positive-sense, single-stranded RNA of
~11 kb with a 5′ cap but no 3′ polyA tract. It encodes a single polypro-
tein that is co- and post-translationally cleaved to generate 3 struc-
tural proteins (E, prM and C) and 7 non-structural proteins (NS1,
NS2a, NS2b, NS3, NS4a, NS4b and NS5). The steps of the viral life
cycle take place in the cytoplasm. WNV infection does not lead to
shut-off of cellular protein synthesis. Viral RNA replication occurs in
vesicles formed by invaginations of the ER membranes (Lindenbach
et al., 2007). Nascent virions are assembled through the interaction
of viral structural proteins associated with ER membranes with a
newly synthesized viral RNA genome followed by budding into the
lumen of the ER. Virions are transported through the Golgi system
to the cell surface (Brinton, 2002; Gubler et al., 2007).
PKR has been reported to play a role in NF-κB signaling and the con-
trol of cell growth through induction of p53 (Garcia et al., 2006) and
also to be involved in IFN, PDGF, TNF-α, p38, JNK, STAT1 and IL-1 signal-
ing (Garcia et al., 2006). The involvement of PKR in thesemultiple cellu-
lar processes requires its phosphorylation (Garcia et al., 2006). A
number of cellular inhibitors have been identiﬁed that can form stable
heterocomplexes with PKR and interfere with a step of the PKR activa-
tion process: (1) dsRNA recognition (C114 and RPL18), (2) dimerization
(p58ipk) or (3) autophosphorylation (Hsp70 and Hsp90) (Garcia et al.,
2007). The catalytic subunit of protein phosphatase 1 alpha (PP1a) de-
phosphorylates PKR resulting in dimer disruption (Tan et al., 2002).
The importance of PKR as a sentinel for the antiviral innate immune
response is highlighted by the many reports indicating that most
known viruses have evolved mechanisms for inhibiting PKR activity
(Garcia et al., 2007). Viral components can either directly inhibit PKR
activation or recruit cellular PKR inhibitors. Viral proteins, including
Kaposi-sarcoma herpesvirus vIRF2 and LANA2, herpes simplex virus 1
(HSV-1) Us11, Epstein-Barr virus SM, vaccinia virus E3L and hepatitis
C virus NS5A and E2 proteins, directly interact with PKR and inhibit ei-
ther its binding to viral dsRNA or its activation. Overexpression of
human papillomavirus E6 protein was reported to induce PKR localiza-
tion to P-bodies where it is sequestered (Hebner et al., 2006). Viruses,
such as adenoviruses and Epstein Barr virus produce small RNA inhibi-
tors of PKR (Langland et al., 2006; Sharp et al., 1993). However, a recent
report suggests that adenovirus also overcomes PKR activation by an al-
ternative viral protein-mediated mechanism (Spurgeon and Ornelles,
2009). Indirect mechanisms include recruitment of cellular p58ipk by
the inﬂuenza NS1 protein into a complex with PKR where it binds to
the PKR dimerization interface preventing activation (Lee et al., 1990)
and recruitment of PP1a by the HSV protein γ134.5 to dephosphorylate
eIF2a (He et al., 1998).
Consistent with our previous data showing that WNV Eg101 infec-
tion does not induce signiﬁcant eIF2a phosphorylation in BHK cells
(Emara and Brinton, 2007), PKR phosphorylation was not signiﬁcantly
induced in rodent cells after infection with either WNV Eg101 or
other “natural” lineage 1 or 2 WNV strains. The activation of PKR in
cells infected withmany other types of viruses resulted in the evolution
of viral-mediated processes to suppress PKR activation or activity. Evi-
dence for a WNV-mediated mechanism of PKR suppression was not
found. Instead, the results indicate that even though someWNVdsRNAs
can activate PKR in vitro, WNV has developed ameans to hide its dsRNA
fromPKRboth at early and late times of the infection cycle so that PKR is
not activated in infected cells.
Results
PKR phosphorylation is not induced by infection of rodent cells with nat-
ural lineage 1 or 2 strains of WNV
PKR can be activated by viral dsRNA and phosphorylates eIF2a lead-
ing to attenuation of cell translation (Garcia et al., 2007).We previously
reported that WNV Eg101 infection of BHK cells did not inducesigniﬁcant eIF2a phosphorylation (Emara and Brinton, 2007). To deter-
minewhether the low level of eIF2a phosphorylation observedwas due
to a lack of PKR activation, PKRphosphorylationwas initially assessed in
mock-infected or WNV Eg101-infected (MOI of 5) C3H/He mouse em-
bryo ﬁbroblasts (MEFs) (IFN-responsive). In mock-infected MEFs trea-
ted with 100 IU/ml of Type I IFN for 24 h, the levels of PKR and Thr451
phosphorylated (P)-PKR increased signiﬁcantly (Fig. 1A). Both the
PKR and P-PKR levels also increased with time after infection in WNV
Eg101-infected MEFs but to lower levels than with IFN treatment.
PKR protein expression is known to be upregulated in response to
Type I IFN signaling (Tanaka and Samuel, 1994; Toth et al., 2006) and
PKR phosphorylation can be induced through direct interactions be-
tween PKR and activated JAK1 and/or Tyk2, two components of the
Type I IFN receptor complex (Su et al., 2007). We previously reported
that IFN-beta expression is upregulated in WNV-infected MEFs by 12 h
after infection and that 100 to 600 IU/ml of IFN beta protein are secreted
into the infected cell culture ﬂuid (Pulit-Penaloza, Scherbik and Brinton,
unpublished data). To determine whether the increases in the PKR and
P-PKR levels observed in C3H/He MEFs were due to IFN-mediated PKR
activation, the upregulation of PKR expression and phosphorylation
was compared in IFNR1−/− and control wild type 129 (129wt) MEFs
infected with WNV Eg101 at a MOI of 5. Cells treated with 100 IU/ml of
Type I universal IFN (PBL Biomedical laboratories, NJ) for 24 h served
as a positive control. As in C3H/He MEFs, a slight increase in P-PKR and
a signiﬁcant increase in PKR levels compared to mock-infected cells
were observed in WNV-infected and IFN-treated 129wt MEFs (Fig. 1B).
In contrast, little if any increase in either PKR or P-PKR levels was ob-
served in WNV-infected or IFN-treated IFNR1−/− MEFs (Fig. 1B).
These results suggested that the small increase in P-PKR levels observed
in WNV-infected MEFs was due to Type I IFN produced and secreted in
response to the infection.
In contrast to the low levels of P-PKR induced by a WNV Eg101 in-
fection in MEFs, a lineage 2/1 chimeric infectious clone-derived WNV
(W956) induced much higher levels of both P-PKR and PKR (Fig. 1C).
The levels of phosphorylated eIF2a were also signiﬁcantly higher in
cells infected with the WNV W956 virus. To determine whether the
Eg101 strain was unique in its inability to induce PKR activation,
IFN-non-responsive BHK cells were infected with Eg101 or another
natural WNV lineage 1 (NY99 or Tx113) or lineage 2 (Mg78 or SPU)
strain at a MOI of 5 for 24 h. Mock-infected BHK cells transfected
with 50 μg/ml of poly(I:C) for 2 h were used as a positive control. Lit-
tle if any increase in PKR phosphorylation compared to mock levels
was observed in BHK cells infected with WNV Eg101 or any of the
four additional WNV strains tested (Fig. 1D). Unexpectedly, a dramat-
ic increase in PKR levels was observed in WNV Eg101-infected BHK
cells but no increase in PKR levels was observed in cells infected
with the other WNV viruses (Fig. 1D). The high degree of upregula-
tion of PKR levels by a WNV Eg101 infection appears to be restricted
to BHK cells since Eg101 infection of neither C3H/He nor 129wt MEFs
induced greater PKR upregulation than IFN treatment and no increase
in total PKR was seen in the WNV Eg101-infected IFNR1−/− MEFs.
This effect also did not correlate with the lineage or virulence of the
virus strains tested. Due to the Type I IFN insensitivity of BHK cells,
the observed PKR upregulation by WNV Eg101 in these cells is
expected to be Type I IFN-independent. Although the mechanism of
PKR expression upregulation in WNV Eg101-infected BHK cells was
not investigated, it was previously reported that the Sp1 and Sp3
transcription factors can upregulate PKR expression in the absence
of IFN (Toth et al., 2006). Overall, the data indicate that infection of
rodent cells with natural strains of WNV does not result in signiﬁcant
upregulation of PKR phosphorylation.
PKR localization in WNV-infected cells
PKR is typically activated in virus-infected cells by dsRNA viral rep-
lication intermediates or hairpin structures within single-stranded
Fig. 1. Analysis of PKR phosphorylation in WNV-infected cells. (A) C3H/He MEFs were mock-infected (M), or infected with WNV Eg101 (MOI of 5) for the indicated times or treated
with 100 U/ml universal type I IFN for 24 h (IFN). (B) 129wt or IFNR1−/−MEFs were mock-infected (M) or infected with WNV Eg101 (MOI of 5) for the indicated times or treated
with 100 U/ml universal Type I IFN for 24 h.(C) C3H/He MEFs were mock-infected or infected with WNV Eg101 or WNV W956 at a MOI of 1 for the indicated times. (D) BHK cells
were mock-infected (M) or infected with WNV Eg101 (MOI of 5) for the indicated times or infected with various strains of WNV (NY99, TX113, SPU and Mg78) for 24 h or trans-
fected with 50 μg/ml poly(I:C) for 2 h (pIC). PKR, phospho-Thr451 PKR, eIF2a, phospho-S51 eIF2a, WNV-NS5 and actin were detected in cell lysates by Western blotting after sep-
aration of proteins by 10% SDS-PAGE.
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region of infected cells in associationwith ERmembranes (Gillespie et
al., 2010; Mackenzie, 2005). To determine whether the cellular distri-
bution of PKR was altered in WNV-infected cells, MEFs and BHK cells
were mock-infected or infected with WNV Eg101 at a MOI of 5 for
10 or 24 h. The cells were ﬁxed, permeabilized and incubated with
anti-PKR and anti-dsRNA antibody and then visualized by confocalmi-
croscopy. PKR was observed to concentrate in the perinuclear region
of infected cells and to co-localize with sites of viral RNA replication
in both MEFs and BHK cells at 10 h and 24 h after infection (Fig. 2A).
This change in PKR cytoplasmic distribution in WNV-infected cells
was also observed when only an anti-PKR primary and a speciﬁc sec-
ondary antibody were used (data not shown). Because PKR serves as
a sentinel of the innate immune response, many different types of vi-
ruses produce proteins that directly interact with PKR and inhibit its
activation (Garcia et al., 2007). To assess PKR colocalization with non-
structural protein components of the WNV replication complex, BHK
cells were mock-infected or infected with WNV Eg101 at a MOI of 5
for 24 or 30 h and PKR and the viral NS1, NS3, or NS5 proteins were
detected by confocal microscopy using viral protein speciﬁc anti-
bodies. No co-localization was observed between PKR and NS3, NS5
or NS1 (Fig. 2B). The observed colocalization of PKR with dsRNA but
not with individual viral replication complex proteins may be due to
the higher signal intensity of the dsRNA antibody and/or to the more
restricted distribution of the viral dsRNA replication intermediates
compared to those of the nonstructural proteins.
As an additional means of assessing whether PKR associates with
viral protein components of the replication complexes, PKR was immu-
noprecipitated from mock-infected and WNV-infected BHK cells and
the precipitates were immunoblotted with anti-NS3 or anti-NS5 anti-
bodies. A species-speciﬁc IgG was used as a negative control. Neither
NS3 nor NS5 co-immunoprecipitatedwith PKR (Fig. 2C). These data sug-
gest that although PKR colocalizes with viral replication complexes, it
does not interact directly with the NS3 protein, which is a marker forthe membrane bound replication complexes, nor with the NS5 (methyl
transferase/RNA-dependent RNA polymerase) protein. However, indi-
rect mechanisms of PKR suppression mediated by these viral proteins
were not ruled out. Antibodies to additionalWNVnonstructural proteins
appropriate for confocal microscopy and co-immunoprecipitation were
not available; therefore, PKR interaction with these proteins could not
be tested.
PKR does not colocalize with known cellular PKR inhibitors in WNV-
infected cells
In addition to inhibiting PKR by direct interaction, viral proteins
have also been reported to recruit cellular PKR inhibitors or sequester
PKR in P bodies (Garcia et al., 2007). To assess whether WNV proteins
recruit cellular PKR inhibitors to associate with PKR and inhibit its acti-
vation inWNV infected cells, BHK cells were infected withWNV Eg101
at a MOI of 5. At 24 h or 30 h after infection, cells were ﬁxed, permeabi-
lized and incubated with anti-PKR antibody and an antibody to a PKR
inhibitor followed by incubation with ﬂuorescently tagged secondary
antibodies and visualization by confocal microscopy. Either a mouse
monoclonal or a rabbit polyclonal anti-PKR antibody was used depend-
ing on the species in which the antibody to the cellular protein being
tested was made. The mouse monoclonal antibody detected nuclear
PKR more efﬁciently than the rabbit polyclonal antibody. With the ex-
ception of PP1a, known cellular PKR inhibitors must remain associated
with PKR to mediate their inhibitory effect and therefore would be
expected to co-localize with PKR. Neither p58ipk nor PP1a concentrated
in the perinuclear regions ofWNV-infected cells or colocalizedwith PKR
(Fig. 3). Similarly, PKR did not localize to P-bodies, detectedwith Dcp1a
antibody, in WNV-infected cells (Fig. 3).
In uninfected cells, cellular protein inhibitors can bind PKR andmod-
ulate its activation. Hsp90 and Hsp70 have both been shown to inhibit
PKR by masking its autophosphorylation sites (Donze et al., 2001;
Pang et al., 2002; Pratt and Toft, 2003). C114, an IL-11 inducible nuclear
Fig. 2. PKR colocalization with sites of WNV replication. (A) Analysis of PKR colocalization with viral replication complexes. BHK cells andMEFs were mock-infected or infected with
WNV Eg101 (MOI of 5). At 10 and 24 h after infection, cells were ﬁxed, permeabilized, and blocked overnight. Cells were stained with anti-PKR and anti-dsRNA antibodies and then
AlexaFluor488 (green) and AlexaFluor594 (red) conjugated secondary antibodies, respectively. Cell nuclei were stained with Hoechst. (B) Analysis of PKR colocalization with viral
nonstructural proteins. BHK cells were mock-infected or infected with WNV Eg101 (MOI of 5). At 24 and 30 h after infection, cells were ﬁxed, permeabilized, and blocked overnight.
Cells were stained with anti-PKR and either anti-NS5, anti-NS3 or anti-NS1 antibodies and then AlexaFluor488 (green) and AlexaFluor594 (red) conjugated secondary antibodies,
respectively. Cell nuclei were stained with Hoechst. (C) Analysis of PKR interaction with viral NS3 or NS5 proteins in infected cells. BHK cells were mock-infected (M), or infected
with WNV Eg101 (MOI of 5). At 26 h after infection, cells were lysed, S2 fractions were prepared and rabbit anti-PKR antibody or a non-speciﬁc rabbit IgG was used for immuno-
precipitation. Immunoprecipitated proteins were separated by 10% SDS-PAGE and detected by Western blotting using anti-NS5 or anti-NS3 antibodies.
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us, can inhibit PKR activation through interaction with the PKR DRBMs
(Yin et al., 2003). Neither Hsp90, Hsp70, nor C114was observed to colo-
calize with PKR in WNV-infected cells (Fig. 3). These data suggest that
suppression of PKR phosphorylation inWNV-infected cells is not medi-
ated by any of these cellular PKR inhibitors.
PKR colocalizes with the PKR inhibitor Nck in WNV-infected cells
Nck is an adapter protein that has been reported to interact with and
directly limit activation of three of the eIF2a kinases PKR, PERK, and HRI,
but not GCN2 and to speciﬁcally modulate eIF2a phosphorylation undervarious stress conditions (Cardin et al., 2007). Nck binds to only the in-
active form of PKR. However, dsRNA can outcompete Nck for PKR bind-
ing leading to PKR activation. In a previous in vitro study, 2 μg/ml of poly
(I:C)was shown to be sufﬁcient to overcomeNck-mediated inhibition of
PKR phosphorylation (Cardin and Larose, 2008). In WNV-infected BHK
cells, Nck concentrated in the perinuclear region and colocalized with
PKR (Fig. 4A). Nck protein levels were high in uninfected cells and did
not increase after WNV-infection in BHK cells (Fig. 4B). Interaction be-
tween Nck and PKR was analyzed by co-immunoprecipitation. Lysates
made fromWNV-infected BHK cells at 24 h after infectionwere incubat-
ed with rabbit anti-PKR antibody or a control nonspeciﬁc rabbit IgG and
the bound proteins were separated by SDS-PAGE and immunoblotted
Fig. 3. Analysis of PKR colocalization with known cellular PKR inhibitors in WNV-infected cells. BHK cells were mock-infected or infected with WNV Eg101 (MOI of 5). At 30 h after
infection, cells were ﬁxed, permeabilized, and blocked overnight. Cells were stained with anti-PKR and an antibody to a cellular PKR inhibitor and then with AlexaFluor488 (green)
and AlexaFluor594/555 (red) conjugated secondary antibodies. PKR was detected with a mouse monoclonal anti-PKR antibody in the PP1a, p58ipk and Dcp1a experiments and with
a rabbit polyclonal antibody in the Hsp70, Hsp90 and C114 experiments.
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a control nonspeciﬁc rabbit IgG was used for immunoprecipitation and
mouse-anti-PKR antibody was used for Western blotting. Nck was co-
immunoprecipitated by PKR antibody but not by the nonspeciﬁc IgG
(Fig. 4C, upper panel). Similarly, PKR was co-immunoprecipitated by
Nck antibody (Fig. 4C, lower panel). A higher amount of PKR was co-
immunoprecipitated by the anti-Nck antibody from WNV-infected cell
lysates than from mock-infected cell lysates consistent with the in-
creased level of PKR in these cells. A decrease rather than an increase
in the Nck-PKR interaction would be expected if the ampliﬁed levels of
viral dsRNA present in infected cells by 24 h had competed with Nck
for binding to PKR. The observed colocalization and association of Nck
and PKR inWNV-infected cells suggested thatmost of the PKR that colo-
calizes with viral dsRNA in infected cells is inactive.
Mammalian genomes have two Nck genes. The Nck-1 and Nck-2
proteins encoded by these genes share 68% amino acid homologyand have been reported to have redundant functions based on the re-
sults of studies with single and double-knockout MEFs (Latreille and
Larose, 2006). As an additional means of determining whether Nck
plays a direct role in inhibiting PKR activation in WNV-infected
cells, double knockout Nck1,2−/− MEFs were infected with WNV
Eg101 at a MOI of 5. Similar to what was observed with control
129wt and C3H/He MEFs (Fig. 1A and B), PKR levels increased
signiﬁcantly in WNV-infected and IFN-treated Nck1,2−/− MEFs
with time after infection (Fig. 4D). However, while only a minimal in-
crease in PKR phosphorylation levels was detected after WNV-
infection of Nck1,2−/−MEFs, a signiﬁcant increase in PKR phosphor-
ylation was observed after IFN-treatment of these cells (Fig. 4D). The
results indicate that even when the PKR-associated inhibitor Nck is
absent, PKR is still only minimally activated in WNV-infected cells.
The level of phosphorylated eIF2awas high in uninfectedNck1,2−/−
MEFs and did not increase after infection or IFN treatment. Nck can form
Fig. 4. Analysis of Nck-PKR interactions inWNV-infected cells. (A) Analysis of colocalization of PKR with Nck. BHK cells were mock-infected or infected with WNV Eg101 (MOI of 5).
At 30 h after infection, cells were ﬁxed, permeabilized, and blocked overnight. Cells were stained with mouse monoclonal anti-PKR and rabbit polyclonal anti-Nck antibodies and
then with AlexaFluor488 (green) and AlexaFluor594/555 (red) conjugated secondary antibodies. (B) Analysis of Nck protein levels in WNV-infected BHK cells. Cells were mock-
infected (M), or infected with WNV Eg101 (MOI of 5) for the indicated times. NS3, Nck-1, and actin were detected by Western blotting after separation of proteins by 10% SDS-
PAGE. (C) Co-immunoprecipitation of Nck and PKR. BHK cells were mock-infected (M) or infected with WNV Eg101 (MOI of 5). At 24 h after infection, cells were lysed and S2 frac-
tions were prepared. Rabbit anti-PKR antibody (top panel) or a rabbit anti-Nck antibody (bottom panel) was used for immunoprecipitation; rabbit IgG was used as a control an-
tibody. Immunoprecipitated proteins were separated by 10% SDS-PAGE and detected by Western blotting using a rabbit anti-Nck antibody (top panel) or a mouse anti-PKR
antibody (bottom panel). (D) Analysis of PKR phosphorylation in WNV-infected Nck-knockout cells. Nck-1,2−/− MEFs were mock-infected (M) or infected with WNV Eg101
(MOI of 5) for the indicated times or treated with 100 U/ml universal Type I IFN for 24 h (IFN). NS3, total PKR, phopho-Thr451 PKR, total eIF2a and phospho-Ser51 eIF2a were
detected by Western blotting after separation of proteins by 10% SDS-PAGE. Blots shown are representative of at least two independent experiments.
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late eIF2a (Latreille and Larose, 2006). The absence of Nck has been
reported to increase the sensitivity of PKR, PERK and HRI kinase activa-
tion and also to reduce the efﬁciency of eIF2a dephosphorylation by
PP1a (Cardin et al., 2007). Consistentwith the higher level of eIF2a phos-
phorylation in Nck1,2−/− MEFs, viral yields from these cells were de-
creased by about 10-fold (data not shown).
PKR autophosphorylation is induced by viral RNAs in vitro
PKR binds dsRNA in a sequence non-speciﬁc manner but the struc-
ture of the RNA plays a critical role in PKR activation. The binding of
an activating dsRNA to PKR leads to the formation of active PKR di-
mers followed by the release of the activating dsRNA. Activated PKR
dimers have been reported to have reduced afﬁnity for poly(I:C)
(Jammi and Beal, 2001; Langland and Jacobs, 1992; Lemaire et al.,
2005). Viral PKR inhibitor RNAs, such as adenovirus VAI RNA and
Epstein-Bar virus EBER-1 RNA, bind to PKR but their structures inhibit
PKR activation (Garcia et al., 2006). Neither of these inhibitor RNAs
induced activation of PKR in vitro at any of the concentrations tested
(McKenna et al., 2006, 2007). In competition assays with an activator
RNA, optimal inhibition by either VAI RNA or EBER-1 RNA was ob-
served when concentrations of these RNAs were 2–10 times higher
than that of an activator RNA.
A WNV genomic RNA fragment consisting of the 3′ terminal 529
nts (3′sfRNA) accumulates in infected cells as well as in mouse brains
(Lin et al., 2004; Scherbik et al., 2006; Urosevic et al., 1997) and is
generated by XRN1 5′ digestion (Pijlman et al., 2008). The 3′sfRNA
is signiﬁcantly larger (529 nts) than known viral PKR inhibitor RNAs
(VAI RNA 136 nts; EBER-1 RNA 157 nts). However, several regionsof the mFold predicted structure of the 3′sfRNA (data not shown)
have similarity to the VAI and EBER-1 RNA structures (McKenna et
al., 2007). The ability of the WNV 3′sfRNA to inhibit PKR activation
was tested in an in vitro PKR autophosphorylation assay. Poly(I:C)
was used as a control activator RNA. Incubation of either poly(I:C)
or 3′sfRNA with puriﬁed recombinant PKR induced PKR autopho-
sphorylation (Fig. 5A).
Flavivirus genomic RNAs contain conserved terminal RNA struc-
tures (Brinton, 2002; Lindenbach et al., 2007). Since the structures
of the WNV 3′ and 5′ terminal stem-loop (SL) RNAs are also similar
to those of known viral RNA PKR inhibitors, the ability of these
RNAs to inhibit PKR activation was also assessed. Both the 3′SL and
5′SL WNV RNAs induced signiﬁcant PKR autophosphorylation; the
5′SL RNA induced a 2-fold greater increase in PKR activation than
the 3′SL RNA (Fig. 5B). Also, preincubation of either of these RNAs
with PKR led to an increase not a decrease in PKR activation by poly
(I:C) above that seen with either RNA alone. The data indicate that
the WNV 3′sf, 3′SL and 5′SL RNAs can activate PKR in vitro.
Poly(I:C)-mediated PKR activation in WNV-infected BHK cells
As an additional means of analyzing whether PKR is actively sup-
pressed in WNV-infected BHK cells, the ability of poly(I:C) to activate
PKR in infected cells was assessed. In preliminary experiments, themin-
imum concentration of poly(I:C) required for maximum intracellular
PKR activation was determined to be 50 μg/ml (data not shown). BHK
cells were mock-infected or infected with WNV Eg101 at a MOI of 5
and at 20 h or 30 h after infection, cells were transfected with
50 μg/ml of poly(I:C) or incubated with transfection reagent alone
for 1.5 h. The observed increase in PKR phosphorylation in response
Fig. 5. In vitro PKR autophosphorylation assays. (A) Reaction mixtures containing 150 ng of puriﬁed PKR alone or with the indicated concentrations of in vitro transcribed WNV 3′
sfRNA or poly(I:C) were incubated as described in Materials and methods. (B) Reaction mixtures containing 150 ng of puriﬁed PKR alone or with the indicated concentrations of in
vitro transcribed WNV 3′SL or 5′SL RNA or with poly(I:C) were incubated for 30 min as described in Materials and methods, or preincubated with the 3′SL or 5′SL for 10 min and
then with poly(I:C) for 30 min. γ32P-ATP was included in the reactions as a phosphate donor. Image Gauge 3.2 software was used to measure the relative band intensities of images
acquired using a Fuji BAS 2500 analyzer. Results are representative of two independent experiments.
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activation is not actively suppressed in WNV-infected BHK cells. In
additional experiments using lower poly(I:C) concentrations (10 or
25 μg/ml), similar levels of PKR activation were observed in infected and
uninfected cells (data not shown). The data indicate that WNV infection
does not interfere with the ability of PKR to respond to a dsRNA activator.
The antiviral effect of PKR in WNV-infected cells was assessed by
comparing viral yields from WNV-infected wildtype and PKR−/−
MEFs. Virus yields in samples of culture ﬂuid collected at the indicated
times after infection with WNV Eg101 (MOI of 5) was determined byFig. 6. Analysis of active suppression of PKR activation in infected cells and of PKR anti-
ﬂaviviral activity. (A) Poly(I:C)-mediated PKR autophosphorylation in WNV-infected
cells. BHK cells were mock-infected or infected with WNV Eg101 (MOI of 5). At 20 or
30 h after infection, cells were transfected with 50 μg/ml of poly(I:C) in Celfectin II
(+) or transfection reagent alone (−) for 1.5 h before cell lysis. PKR, phopho-Thr451
PKR and actin were detected in cell lysates by Western blotting after separation of pro-
teins by 10% SDS-PAGE. (B) Viral yields produced by PKR−/− and wildtype MEFs
infected with WNV Eg101 (MOI of 5). Samples of culture ﬂuid were harvested at the
indicated times, and infectivity titers were determined by plaque assays done in dupli-
cate on BHK cells. Virus titers are expressed as log10 PFU/ml. Error bars indicate
±standard error of the mean (SEM) (n=3).plaque assay on BHK cells. Comparable virus titers were observed in
both cell types at 12, 24 and 36 h after infection (Fig. 6B) indicating
that PKR antiviral activity does not affect WNV yield.
Discussion
PKR is activated by viral dsRNA and exerts its antiviral effect through
phosphorylation of eIF2a. Because eIF2a phosphorylation leads to atten-
uation of protein synthesis, many viruses have evolved mechanisms to
block or suppress PKR activation. Some viruses use alternative transla-
tional mechanisms. For example, caliciviruses encode viral proteins
that act as cap-analogs while picornaviruses initiate translation from
an internal ribosome entry site (IRES) in an eIF2a-independent manner
(Lopez-Lastra et al., 2010). Other viruses produce a small RNA or a viral
protein that either directly or indirectly inhibits PKR activity (Garcia et
al., 2007). WNV genome RNA translation is cap-dependent and so
would be susceptible to eIF2a-mediated translation inhibition. However,
shut-down of host translation does not occur in ﬂavivirus infected cells
(Lindenbach et al., 2007). We previously reported only low levels of
eIF2a phosphorylation in WNV-infected BHK cells (Emara and Brinton,
2007). Consistent with this observation, no increase in PKR phosphory-
lation in WNV-infected BHK cells and only a slight increase in infected
wild type MEFs mediated by IFN was observed in the present study.
The authors of a previous study done with WNV virus-like particles
(VLPs) containing WNV replicons concluded that PKR activation pro-
vides antiviral protection againstWNV (Gilfoy andMason, 2007). How-
ever, a similar number of foci forming units (FFU)were detected inwild
type and PKR−/− MEFs 48 h after infection with WNV VLPs and IFN-
treatment led to a reduction in FFUs in wild type but not in PKR−/−
MEFs suggesting that the PKR activation observed was mediated by
IFN and not by WNV dsRNA. The results of this previous study are con-
sistent with those of the present study. An additional previous study,
that utilized VLPs containing a WNV replicon with a C-terminal EMCV
IRES driving translation of a neomycin gene ORF (Jiang et al., 2010),
reported a reduction in virus yield from cells overexpressing PKR com-
pared to control cells. The EMCV IRES was previously shown to activate
PKR in vitro and in vivo (Arnaud et al., 2010; Shimoike et al., 2009) and
may have contributed to the PKR activation observed.
Suppression of PKRby known cellular inhibitors requires association
with PKR (Garcia et al., 2007). Among the cellular inhibitors tested, only
Nck colocalized with PKR that concentrated in the perinuclear region of
WNV-infected cells. Since Nck interactswith inactive PKR, the detection
of Nck colocalizing with PKR in the perinuclear region of infected cells
suggested that the majority of the PKR in this region is in an inactive
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uninfected cells suggested that this interaction was not disrupted by
WNV infection. It was previously reported that a minimum of 2 μg/ml
of poly(I:C) was sufﬁcient to outcompete Nck binding to PKR (Cardin
and Larose, 2008). However, even though the WNV genome RNA and
the 3′sfRNA, which were shown to contain several structures that
could activate PKR in vitro, as well as viral dsRNA replicative intermedi-
ates increase exponentially between 6 and 24 h after infection, these
viral RNAs did not compete with Nck for binding to PKR. The minimal
activation of PKR detected inWNV-infectedNck1,2−/−MEFs provided
additional evidence that PKR was not activated by viral dsRNA in
infected cells and the observation that poly(I:C) induced signiﬁcant
PKR phosphorylation in WNV-infected cells suggested that PKR phos-
phorylation is not actively suppressed in WNV-infected cells. The simi-
lar virus yields produced by wildtype and PKR−/−MEFs infected with
WNV provided additional conﬁrmation that PKR does not mediate sig-
niﬁcant antiviral activity inWNV-infected cells. PKRwas reported to as-
sociate with ER membranes (Garcia et al., 2007) and the perinuclear
concentration of PKR observed in WNV-infected cells could be a by-
stander effect of virus-directed ER membrane rearrangement rather
than due to recruitment by a viral component.
Although the reasons why viral RNA does not bind to and activate
PKR inWNV-infected cells are not known, some of the known character-
istics of ﬂavivirus infections provide possible clues. The viral capsid pro-
tein forms dimers that associate with ER membranes and viral RNA
(Lindenbach et al., 2007) and these interactions may prevent PKR from
binding to the genomic RNA. Also, theWNV genomic 3′SL RNAwas pre-
viously reported to bind to several cellular proteins that are thought to
be required for efﬁcient initiation of viral minus strand RNA synthesis
(Brinton, 2002; Davis et al., 2007) and the interactions with these pro-
teinsmay prevent the interaction of this SLwith PKR. TheWNVgenomic
RNA contains a 5′ cap, an RNAmodiﬁcation reported to prevent PKR ac-
tivation by cellular RNAs (Nallagatla et al., 2007). Interactions between
the 5′SL and translation factors may mask this structure from detection
by PKR. Alternatively, the reported interaction betweenNS5 and 5′nts of
the viral genome (Dong et al., 2008) may prevent the RNA structures in
this region from interacting with PKR. Flaviviruses replicate in the cyto-
plasm and induce extensive ER membrane proliferation and rearrange-
ment. Perinuclear vesicles that are formed by invaginations of the rough
ER membrane contain the double-stranded viral RNA replication inter-
mediates and once formed facilitate an exponential ampliﬁcation of ge-
nome RNA (Gillespie et al., 2010; Mackenzie, 2005;Welsch et al., 2009).
At later times in the infection cycle, the sequestering of replicating
dsRNA in vesicles, the close proximity of viral RNA replication sites to
sites of genome RNA translation andpackaging and themembrane asso-
ciation of the capsid proteins may all participate in the evasion of WNV
dsRNA regions fromdetection by PKR. However, it is not knownhow the
viral RNAs are hidden from PKR during the early stages of the infection
cycle when viral genome and antisense RNA replication occurs symmet-
rically at low levels (Lindenbach et al., 2007). Possibly the viral RNA
levels are not high enough to outcompete Nck efﬁciently.
Viral RNA tertiary interactions may play a role in preventing interac-
tion with PKR. Also, GU wobble pairs in RNAs were previously shown to
inhibit PKR activation in vitro (Nallagatla and Bevilacqua, 2008). Not only
the number but also the clustering of GU pairs is required to sufﬁciently
alter a dsRNA structure so that it is unable to activate PKR (Nallagatla and
Bevilacqua, 2008). More than 500 GU wobble base pairs (bp) were pre-
dicted to form in a whole genome fold of theWNV Eg101 RNA (Ann Pal-
menberg, unpublished data). In the context of the whole genomic RNA,
13 of the 22GUpairs formed by the small 3′sfRNA sequence are long dis-
tance interactions between nts in this region and nts located near the 5′
end of the viral RNA and most of these GU pairs are clustered. However,
the “free” 3′sfRNA is predicted to formonly 12GUpairs and these are not
clustered. The decrease in GU pairs would be expected to increase the
ability of the “free” 3′sfRNA to activate PKR. The location of the small 3′
sfRNAs that accumulate in infected cells is not known. They may alsobe “hidden” from PKR though association with multiple cell proteins
and/or be sequestered in a cell compartment.
The ﬁnding that WNV infections do not actively suppress PKR is a
novel mechanism of viral evasion of the antiviral activity of PKR. In
contrast to infections with the natural WNV strains tested in this
study, aW956 chimeric virus infection efﬁciently activated PKR. Stud-
ies are currently underway utilizing the W956 virus as a tool to gain
additional insights about how natural WNV strains avoid activating
PKR (Courtney, Scherbik and Brinton, unpublished data).
Materials and methods
Cell lines and viruses
Simian virus 40 (SV40)-transformed C3H/He and C57BL/6 mouse
embryo ﬁbroblast (MEF) lines, as well as BHK-21 WI2 cells (Vaheri
et al., 1965), were grown as previously described (Scherbik et al.,
2006). PKR+/+ and PKR−/− (generated by Charles Weissmann,
Scripps Research Institute and provided by Scott Kimball, Pennsylvania
State University), IFNR1−/− and 129 wild-type (129wt) (provided by
Herbert Virgin,Washington University, St. Louis,Mo), Nck1,2−/− (pro-
vided by Tony Pawson, Samuel Lunenﬁeld Research Institute, Ontario,
Canada) MEFs were maintained at 37 °C in 5% CO2 in Dulbecco's modi-
ﬁed Eagle medium (DMEM) containing high glucose, 10% heat inacti-
vated fetal bovine serum (FBS), 100 μg/ml streptomycin and 100 IU/ml
penicillin.
Aliquots of lineage 1 (Eg101, Tx113 and NY99) and lineage 2 (SPU
andMg78) strains ofWNVwere obtained from Robert Tesh (University
of Texas Medical Branch, Galveston, TX). A pool of each virus was pre-
pared by infecting BHK cells at a MOI of 0.1 and harvesting culture
ﬂuid 32 h after infection. Clariﬁed culture ﬂuid (1×108PFU/ml, Eg101;
3×106PFU/ml, Tx113; 5×107PFU/ml, NY99; 2×107PFU/ml, SPU;
3×106PFU/ml, Mg78) was aliquoted and stored at−80 °C. Plaque as-
says to measure virus infectivity titers were done in BHK cells as previ-
ously described (Scherbik et al., 2006). The construction of the lineage
2/1 chimeric virus genome, referred to as W956, was described previ-
ously (Yamshchikov et al., 2001). The W956 genome sequence from
the 5′ end through the N-terminus of NS5 is from a highly passaged
WNV lineage 2 D117B956 strain while the 3′ 1496 nts are from the lin-
eage 1 Eg101 strain. A stock of this virus was produced by transfecting
BHK cells with 1 μg of in vitro transcribed infectious clone RNA and har-
vesting culture ﬂuid 72 h after transfection. Clariﬁed culture ﬂuid
(~5×107PFU/ml) was aliquoted and stored at−80 °C.
Confocal microscopy
BHK cells (2×103 cells per well) were seeded on 12.5-mm coverslips,
in 24-well plates and 24 h later, the cells were counted and infectedwith
WNV Eg101 at a MOI of 5. At the indicated times, cells were ﬁxed in 4%
paraformaldehyde and then permeabilized using cold 100% methanol.
The cells werewashed in PBS and incubated overnight at 4 °C in blocking
buffer (5% heat inactivated horse serum in PBS). The cellswere then incu-
bated with a primary antibody diluted in blocking buffer for 1 h at room
temperature,washed three timeswith PBS, and incubated for 1 h at room
temperature with AlexaFluor -488, -594 or -555 conjugated secondary
antibodies (Invitrogen) diluted in blocking buffer. Cell nuclei were
stained with 0.5 μg/ml Hoechst 33258 (Molecular Probes) added during
the secondary antibody incubation. Coverslips were mounted with
Prolong mounting medium (Invitrogen), and the cells were viewed and
photographed with a Zeiss LSM 510 confocal microscope (Zeiss,
Germany) using either a 63× or 100× oil immersion objective. The
images were merged and analyzed using Zeiss software version 3.2. The
same camera settings were used for all images in an experimental
series. Primary antibodies used were: mouse monoclonal anti-PKR
(B10) (1:100) or rabbit polyclonal anti-PKR (1:100) (Santa Cruz Biotech-
nology), mouse anti-dsRNA (1:200) (English and Scientiﬁc Consulting,
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(1:300) (R&D Systems), mouse anti-WNV NS5 (1:700) (a gift from Pei-
Yong Shi, Wadsworth Center, NY State Department of Health, NY),
mouse anti-Hsp90 (1:100) (Stressgen), mouse anti-Hsp70 (1:100)
(Stressgen), rabbit anti-p58ipk (1:100) (Cell Signaling), rabbit anti-PP1a
(1:100) (Cell Signaling), anti-Dcp1a (a gift from J. Lykke-Anderson, Uni-
versity of Colorado, Boulder, CO), rabbit anti-Nck (1:100) (Millipore),
mouse anti-C114 (1:100) (Sigma Aldrich) and mouse-anti-RLP18
(1:500) (Sigma Aldrich).
Co-immunoprecipitation assay
BHK cells (2×107) were mock-infected or infected with WNV at a
MOI of 5. At 26 h after infection, cells were collected in NP-40 lysis buff-
er [50 mM sodium phosphate (pH 7.2), 150 mMNaCl, 1% Nonidet P-40,
and EDTA-free Complete Mini Protease Inhibitor Cocktail (Roche)]. Cell
lysates were incubated on ice for 30 min, sonicated, and then centri-
fuged at 2000×g for 5 min at 4 °C to make S2 fractions. S2 lysates
(500 μl per reaction containing ~500 μg of total protein)were incubated
with 1 μg of rabbit anti-PKR or a nonspeciﬁc rabbit IgG antibody over-
night at 4 °C with rotation. Protein G-magnetic beads (New England
Biolabs) were added and incubation was continued for 1 h. Beads
were collected magnetically, washed seven times with 1 ml of lysis
buffer, and proteinswere eluted by boiling for 5 min. Proteinswere sep-
arated by 10% SDS/PAGE, transferred to nitrocellulose membranes, and
analyzed by Western blotting using one of the following antibodies:
mouse anti-PKR (Santa Cruz), rabbit anti-Nck (Millipore), mouse anti-
NS5 (a gift from Pei-Yong Shi, Wadsworth Center, NY State Department
of Health, NY) or goat anti-NS3 (R&D systems).
Western blot analysis
Cells were seeded into 12-well plates and grown to ~100% con-
ﬂuency and infected at a MOI of 5. Cells were lysed in RIPA buffer
[1× PBS, 1% NP-40, 0.5% sodium deoxycholate, 1% SDS and protease
inhibitor cocktail (Roche)] at the indicated times after infection, ly-
sates were collected and 2× Sample Buffer [8% SDS, 25% glycerol,
100 mM Tris–HCl (pH 6.8), 0.5% bromophenol blue, and 5% 2-
mercaptoethanol] was added. The samples were boiled for 5 min
and proteins were resolved by SDS-PAGE. The proteins were trans-
ferred to a nitrocellulose membrane. The membrane was blocked
with 5% BSA or 5% non-fat dry milk (NFDM) in 1× TBS+0.05%
Tween-20 (TBST) for 1 h at room temperature. A primary antibody
was then incubated with the membrane overnight at 4 °C, the mem-
branes were washed 3 times in 1× TBST and then incubated with a
secondary antibody diluted in 5% NFDM-TBST for 1 h at room temper-
ature. After washing the membrane twice in 1× TBST and once in 1×
TBS, membranes were processed for enhanced chemiluminescence
using a Super-Signal West Pico or Femto detection kits (Pierce, Rock-
ford, IL) according to the manufacturer's instructions. Membranes
were incubated with one of the following primary antibodies: anti-
p-eIF2a (Ser51) (Cell Signaling) (1:500 in 5% BSA-TBST) and anti-
eIF2a (1:1000 in 5% NFDM-TBST) (Cell Signaling), anti-PKR (1:3000
in 5% NFDM-TBST) (Santa Cruz), anti-PKR-pT451 (1:500 in 5% BSA-
TBST) (Millipore), anti-Nck (1:1000 in 5% NFDM-TBST) (Millipore)
or anti-actin (1:40,000 in 5% NFDM-TBST) (Abcam). Anti-Rabbit-
HRP (1:2000) or anti-Mouse-HRP (1:2000) (Cell Signaling) secondary
antibodies were both diluted in 5% NFDM-TBST.
In vitro transcription of viral RNA
WNV3′(+)SL RNA, WNV5′ (+)SL RNA, and the WNV 3′ small frag-
ment RNA (3′sfRNA) were in vitro transcribed using a MAXIscript in
vitro transcription kit (Ambion) in 20-μl reactions containing T7 RNA
polymerase (30U), a PCR puriﬁcation kit (Qiagen)-puriﬁed PCR product
(1 μg), 0.8 mM [α-32P]GTP (3,000 Ci/mmol, 10 mCi/ml; Perkin Elmer),and 0.5 mMof CTP, UTP, and ATP. Unlabeled viral RNAwas in vitro tran-
scribed as described above, except that 0.5 mM of each of the four nu-
cleoside triphosphates was added to the reaction mixture. The in vitro
transcription mixture was incubated at 37 °C for 2 h, and transcription
was stopped by the addition of DNase I (1 U). The reaction mixture
was heated at 95 °C for 5 min in 2× Gel Loading Buffer II (Ambion)
and the RNA transcripts were puriﬁed by electrophoresis on a 6% poly-
acrylamide gel containing 7 M urea. Thewet gel was autoradiographed,
the 32P-labeled RNA band as well as unlabeled RNA bands loaded onto
adjacent laneswere excised. RNAwas eluted from the gel slices by rock-
ing overnight at 4 °C in elution buffer [0.5 M NH4OAC, 1 mM EDTA, and
0.2% SDS]. Eluted RNA was ﬁltered through a 0.45-μm cellulose acetate
ﬁlter unit (Millipore), ethanol-precipitated, resuspended in water, ali-
quoted, and stored at−80 °C. The amount of radioactivity incorporated
into each RNA probe was measured in a scintillation counter (model
LS6500; Beckman), and the speciﬁc activity was estimated using
Ambion's speciﬁc activity calculator (Ambion). Unlabeled RNA concen-
trations were calculated based on UV absorbance measured at 260 nm.RNA secondary structure prediction
The secondary structure of each RNA probe used in this study was
predicted using Mfold version 3.1 software (Zuker, 2003).PKR autophosphorylation assay
Recombinant humanPKRexpressed andpuriﬁed from E. coliwas a gift
from Graem Conn, Emory University (Conn, 2003). Puriﬁed PKR (150 μg)
was incubatedwith in vitro transcribed viral RNAs in kinase buffer [5 mM
Tris–HCl, (pH 7.6), 1 mM MgCl2, 25 mM KCl, 0.25% Triton-X 100, and
RNase Inhibitor (Ambion)] on ice for 10 min. Poly(I:C), 4× Mg/ATP cock-
tail (Millipore) [20 mMMOPS, pH 7.2, 25 mMβ-glycerophosphate, 5 mM
EGTA, 1 mM Na3VO4, 1 mM dithiothreitol, 75 mM MgCl2, and 0.5 mM
ATP] and 10 μCi 32p-γ-ATP (Perkin Elmer) were added to the reactions
and incubated at 30 °C for 20 min. The reactionswere stoppedby addition
of 2× Sample Buffer [8% SDS, 25% glycerol, 100 mM Tris–HCl (pH 6.8),
0.5% bromophenol blue and 5% 2-mercaptoethanol added fresh], and
the proteins were resolved by SDS-PAGE. Gels were ﬁxed in 30% metha-
nol and 10% acetic acid, incubated in Autoﬂuor image intensiﬁer solution
(National Diagnostics) and then incubated in anti-cracking buffer [7%
methanol, 7% acetic acid and 1% glycerol] at room temperature, dried
and analyzed using a Fuji BAS 2500 analyzer (Fuji Photo Film Co.) and
Image Gauge software (Science Lab, 98, version 3.12; Fuji Photo Film Co.).Poly(I:C) transfection
To activate intracellular PKR, different concentrations of poly(I:C)
(Sigma Aldrich) in the range of 1 to 100 μg were transfected into BHK
cell monolayers in 12-well plates. Brieﬂy, 5 μl of poly(I:C) was diluted
in 95 μl OptiMEM I Reduced Serum media (Invitrogen) and incubated
with 5 μl Celfectin II transfection reagent (Invitrogen) diluted in 95 μl
OptiMEM for approximately 20 minutes. The poly(I:C)–Celfectin com-
plexes were added to the cell monolayers (200 μl per well), the volume
was increased to 1 mlwith OptiMEMand themonolayerswere incubat-
ed for 1.5 or 2 h at 37 °C.Acknowledgments
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